Clinical Trial Update: Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 neoadjuvant trial of weekly carboplatin plus paclitaxel for triple-negative breast cancer; the trial is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Triple Negative Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING